Pivotal bioVenture Partners Investment Advisor LLC - VAXCYTE INC ownership

VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 264 filers reported holding VAXCYTE INC in Q2 2024. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.

Quarter-by-quarter ownership
Pivotal bioVenture Partners Investment Advisor LLC ownership history of VAXCYTE INC
ValueSharesWeighting
Q2 2024$59,882,148
+10.5%
793,0360.0%46.04%
+32.2%
Q1 2024$54,172,494
+8.8%
793,0360.0%34.82%
+175.6%
Q4 2023$49,802,661
+23.2%
793,0360.0%12.63%
-21.7%
Q3 2023$40,429,128
+2.1%
793,0360.0%16.12%
+23.5%
Q2 2023$39,604,218
+52.5%
793,036
+14.4%
13.06%
+22.1%
Q1 2023$25,975,102
-21.8%
693,0390.0%10.70%
-26.0%
Q4 2022$33,231,220
+78.4%
693,039
-10.7%
14.45%
+112.3%
Q3 2022$18,625,000
+2.9%
776,039
-6.7%
6.81%
-25.4%
Q2 2022$18,108,000
-32.5%
832,166
-25.1%
9.12%
-28.2%
Q1 2022$26,842,000
+1.5%
1,111,4850.0%12.70%
+14.9%
Q4 2021$26,442,000
-25.8%
1,111,485
-20.9%
11.06%
-12.3%
Q3 2021$35,656,000
+12.7%
1,405,4210.0%12.60%
+1.1%
Q2 2021$31,636,000
+14.0%
1,405,4210.0%12.47%
+40.0%
Q1 2021$27,757,000
-53.0%
1,405,421
-36.8%
8.90%
-54.3%
Q4 2020$59,064,0002,222,97019.47%
Other shareholders
VAXCYTE INC shareholders Q2 2024
NameSharesValueWeighting ↓
Abingworth LLP 4,168,718$99,174,00024.03%
Medicxi Ventures Management (Jersey) Ltd 1,887,478$44,903,00011.24%
Pivotal bioVenture Partners Investment Advisor LLC 1,111,485$26,442,00011.06%
FRAZIER MANAGEMENT LLC 2,309,554$54,944,0004.23%
Kynam Capital Management, LP 211,483$5,031,0002.69%
GREAT POINT PARTNERS LLC 500,000$11,895,0002.64%
Ghost Tree Capital, LLC 250,000$5,948,0002.13%
RA Capital Management 4,240,464$100,881,0001.78%
Opaleye Management Inc. 315,800$7,513,0001.59%
Ikarian Capital, LLC 295,111$7,021,0001.05%
View complete list of VAXCYTE INC shareholders